Literature DB >> 6982752

Massive vincristine overdose: failure of leucovorin to reduce toxicity.

L L Thomas, P C Braat, R Somers, R Goudsmit.   

Abstract

The case history of a 24-year-old male with the nodular sclerosing form of Hodgkin's disease (stage IIE) who accidentally received an overdose of vincristine (25 mg, 0.39 mg/kg) is reported. To date, ten patients given a vincristine overdose have been reported. Two of those patients were treated with leucovorin. One patient died after 68 hours. In the second patient, the time to onset and the duration of symptoms were shortened. In an attempt to reduce the duration of toxic effects in our patient, leucovorin was administered 24 hours after the overdose. In agreement with the earlier observation, the time to onset of symptoms was short, but in contrast we did not find a more rapid recovery from the serious side effects. Although the patient might have died without leucovorin administration, we believe its beneficial effect remains to be established.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982752

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  7 in total

1.  Accidental iatrogenic intoxications by cytotoxic drugs: error analysis and practical preventive strategies.

Authors:  B Zernikow; E Michel; G Fleischhack; U Bode
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

2.  Improved tolerance of vincristine by glutamic acid. A preliminary report.

Authors:  D V Jackson; E K Pope; L D Case; H B Wells; D R White; M R Cooper; R D Caldwell; W R Black; H B Muss; J M Cruz
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

Review 3.  Clinical management of cytotoxic drug overdose.

Authors:  L L Thomas; M J Mertens; A E von dem Borne; C J van Boxtel; C H Veenhof; E P Veies
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

4.  Clinical trial of pyridoxine to reduce vincristine neurotoxicity.

Authors:  D V Jackson; E K Pope; R A McMahan; M R Cooper; J N Atkins; R D Callahan; E H Paschold; R A Grimm; J O Hopkins; H B Muss
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

5.  Clinical trial of folinic acid to reduce vincristine neurotoxicity.

Authors:  D V Jackson; R A McMahan; E K Pope; L D Case; M R Cooper; M K Kaplon; F Richards; J J Stuart; D R White; P J Zekan
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Successful management and recovery of a dog with immune-mediated thrombocytopenia following vincristine overdose.

Authors:  Maude Poirier; April E Blong; Rebecca A L Walton
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-02-07

7.  Accidental overdose of multiple chemotherapeutic agents.

Authors:  I S Kim; A Gratwohl; C Stebler; M Hausmann; A Tichelli; A Stern; B Speck
Journal:  Korean J Intern Med       Date:  1989-07       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.